Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies

Anticancer Research

Volumn 27, Issue 6 C, 2007, Pages 4315-4320

  Taymoorian, Kasra ^a   Thomas, Anke ^a,c   Slowinski, Torsten ^a   Khiabanchian, Masoud ^b   Stephan, Carsten ^a   Lein, Michael ^a   Deger, Serdar ^a   Lenk, Severin ^a   Loening, Stefan A ^a   Fischer, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Department of Internal Medicine Caritas Hospitals Pankow ^*  (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Biopsy; Contrast medium; Prostate; Prostatic neoplasms; Ultrasonography

Indexed keywords

ECHO CONTRAST MEDIUM; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOPPLER ECHOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; ARTIFACTS; BIOPSY; CONTRAST MEDIA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER;

EID: 37549024541     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Chang JJ, Shinohara K, Bhargava V and Presti JC Jr: Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160: 2111-2114, 1998.
2. Keetch DW, Catalona WJ and Smith DS: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151: 1571-1574, 1994.
3. Ellis WJ and Brawer MK: Repeat prostate needle biopsy: who needs it? J Urol 153: 1496-1498, 1995.
4. Nagata M, Sato T, Un-no T et al: Repeat prostate biopsy in patients with previous negative biopsies. Hinyokika Kiyo 48: 589-592, 2002.
5. Niemann TR and Bahnson RR: Extended sector biopsy for detection of carcinoma of the prostate. Urol Oncol 6: 91-93, 2001.
6. Djavan B, Remzi M, Schulmann C et al: Repeat prostate biopsy: who, how and when? A review. Eur Urol 42: 93-103, 2002.
7. Djavan B, Milani S and Remzi M: Prostate biopsy: who, how and when? An Update. Can J Urol 12: 44-48, 2005.
8. Cornud F, Peyromaure M, Veillefond A et al: Comment nous faisons une biopsie de prostate. Feuillets de radiologie 45: 297-307, 2005.
9. Djavan B, Zlotta A, Remzi M et al: Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1, 051 men. J Urol 163: 1144-1148, 2000.
10. Roehrbohrn CG, Pickens GJ and Sanders JS: Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. Urology 47: 347-352, 1996.
11. Ghani KR, Dundas D and Patel U: Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int 94: 1014-1020, 2004.
12. Dang CV and Semenza GL: Oncogenic alterations of metabolism. Trends Biochem Sci 24: 68-72, 1999.
13. Bartsch G, Horninger W, Klocker H et al: Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 58: 417-424, 2001.
14. Tanaka N, Samma S, Joko M et al: Diagnostic usefulness of endorectal magnetic resonance imaging with dynamic contrast-enhancement in patients with localized prostate cancer: mapping studies with biopsy specimens. Int J Urol 6: 593-599, 1999.
15. Frauscher F, Pallwein L, Klauser A et al: Ultrasound contrast agents and prostate cancer. Radiologe 45: 544-551, 2005.
16. Forsberg F, Merton DA, Liu JB et al: Clinical applications of ultrasound contrast agents. Ultrasonics 36: 695-701, 1998.
17. Roy C, Buy X, Lang H, Saussine C and Jacqmin D: Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 170: 69-72, 2003.
18. Hodge KK, Mcneal JE, Terris MK and Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142: 71-75, 1989.
19. Colombo T, Schips L, Augustin H et al: Value of transrectal ultrasound in preoperative staging of prostate cancer. Minerva Urol Nefrol 51: 1-4, 1999.
20. Resnick NI, Willard JW and Boyce WH: Ultrasonic evaluation of the prostatic nodule. J Urol 120: 86-89, 1981.
21. Rifkin M, Sudakoff G and Alexander A: Prostate: techniques, results and potential applications of color Doppler US scanning. Radiology 186: 509-513, 1993.
22. Kelly I, Lees W and Rickards D: Prostate cancer and the role of color Doppler US. Radiology 189: 153-156, 1993.
23. Bree RL: The role of color Doppler and staging biopsies in prostate cancer detection. Urology 49: 31-34, 1997.
24. Ismail M, Petersen RO, Alexander AA et al: Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 50: 906-912, 1997.
25. Lavoipierre AM, Snow RM, Frydenberg M et al: Prostatic cancer: role of color Doppler imaging in transrectal sonography. Am J Roentgenol 171: 205-210, 1998.
26. Cornud F, Belin X, Piron D et al: Color Doppler guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for non palpable lesions. Urology 49: 709-715, 1997.
27. Zackrisson B, Aus G, Bergdahl S et al: The risk of finding focal cancer (less than 3mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable. J Urol 171: 1500-1503, 2004.
28. Roobol MJ, Van der Cruijsen IW and Schroder FH: No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam). Urology 63: 892-897, 2004.
29. Moran BJ, Braccioforte MH and Conterato DJ: Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol 176: 1376-1381, 2006.
30. Watanabe M: Color Doppler enhancement with contrast agents for the detection of prostatic cancer. Nippon Rinsho 56: 1040-1044, 1998.